Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04451525 · ClinicalTrials.gov registry record
REal-World Analyses of Stroke - Thrombus Occlusion REtrieval
A clinical trial, sponsored by Microvention-Terumo.
- Completed
- Registry status
- 710
- Enrollment target
NCT04451525: Completed study, sponsored by Microvention-Terumo.
NCT04451525 is a clinical trial that has completed, run by Microvention-Terumo. The registered enrollment target is 710 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04451525 has completed, sponsored by Microvention-Terumo.
- COMPLETED
- Registry status
- 710 participants
- Enrollment target
Study Summary
To collect real-world evidence allowing assessment of functional, imaging, and safety outcomes of MicroVention market-released acute ischemic stroke devices when used at the direction of the treating physician.
Interventions
- DEVICE MicroVention Mechanical Thrombectomy Devices as first-line treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 710 participants |
| Start Date | 2020-07-15 |
| Est. Completion | 2025-06-09 |
What the finished NCT04451525 record still lists
NCT04451525 is an observational study that tracks outcomes without assigning an intervention. The registered 710 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which MicroVention Mechanical Thrombectomy Devices as first-line treatment is the first listed.
NCT04451525 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04451525 about?
NCT04451525 is a clinical study titled "REal-World Analyses of Stroke - Thrombus Occlusion REtrieval". To collect real-world evidence allowing assessment of functional, imaging, and safety outcomes of MicroVention market-released acute ischemic stroke devices when used at the direction of the treating physician.
What is the current status of trial NCT04451525?
This trial is currently completed. The enrollment target is 710 participants. The study started on 2020-07-15. Estimated completion is 2025-06-09.
What interventions are being tested in trial NCT04451525?
The interventions under investigation include: MicroVention Mechanical Thrombectomy Devices as first-line treatment (DEVICE).
Who is sponsoring clinical trial NCT04451525?
This trial is sponsored by Microvention-Terumo, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06179160 · 710 participants · Phase 1
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- NCT06235697 · 710 participants · Phase 3
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
- NCT06470867 · 710 participants · NA
Randomized Controlled Effectiveness Trial of VA S.A.V.E.
- NCT07022483 · 710 participants · Phase 3
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI